[1]
“Development and Evaluation of Nasal Microsphere Formulations for Enhanced Nose-to-Brain Delivery of Lorazepam in Epilepsy”, InPharTech, vol. 1, pp. 37–44, Mar. 2025, Accessed: Jul. 20, 2025. [Online]. Available: https://amepurvapub.com/index.php/InsightsPharmatech/article/view/8